Overview

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess potential interactions between intravenous (i.v.) cocaine and atomoxetine (Strattera) administered orally in four escalating doses.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Atomoxetine Hydrochloride
Cocaine
Criteria
Inclusion Criteria:

- 18-45 years of age who are not seeking treatment at the time of the study

- Must be able to provide written informed consent

- Must be within 20 percent of ideal body weight and weigh at least 45 kg

- Must meet DSM0IV diagnostic criteria for cocaine abuse or dependence

- Must currently be using cocaine as confirmed by a positive BE

- If female and of child bearing potential, must agree to the use of birth control

Exclusion Criteria:

- please contact the site directly for more information